Report Detail
Global Antifungal Drug Market - Premium Insight, Industry Trends, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update)
- RnM2798441 |
- 14 March, 2019 |
- Global |
- 131 Pages |
- 360iResearch |
- Other
The global antifungal drug market is expected to grow from USD 14.22 billion 2017 to USD 18.92 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 4.17%.
“Growing prevalence of fungal infection due to climateis one of the factors largely attributing to the growth of antifungal drug market globally”
The factors attributing to the growth of the market are growing prevalence of fungal infection due to climate, high awareness levels pertaining to myriad fungal infections, increased demand for the drugs to combat the related diseases, and favorable government initiative and corporate funds. However, some factors such as continued preference for conventional antifungal drugs, and growing population with antifungal drug resistance may hinder the market growth. The global antifungal drug market is expected to showcase the opportunities such as increased r&d funding and focus on product innovation, and patent expiration of branded drugs. In the near future, the market may face the possible challenges in the growth due to potential side effects, and presence of counterfeit drugs and resistance toward antifungal drugs. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global antifungal drug market market.
On the basis of form, the global antifungal drug market is studied across Ointments, Powder, and Tablets.
On the basis of infection type, the global antifungal drug market is studied across Superficial Fungal Infection and Systemic Fungal infection.
On the basis of therapeutic indications, the global antifungal drug market is studied across Aspergillosis, Candidiasis, and Dermatophytosis.
On the basis of type, the global antifungal drug market is studied across Allylamines, Azoles, Echinocandins, and Polyenes.
On the basis of geography, the global antifungal drug market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).
“Abbott Laboratories: The potential growing player for the global antifungal drug market”
The key players profiled in the global antifungal drug market are Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Enzon Pharmaceuticals, Inc., Gilead Sciences, Inc., GlaxoSmithKline plc, Kramer Laboratories, Inc., Merck Group, Novartis AG, Pfizer, Inc., SCYNEXIS, Inc., Sanofi-Aventis SA, and Sigma-Aldrich, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global antifungal drug market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global antifungal drug market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global antifungal drug market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global antifungal drug market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global antifungal drug market.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Instruments
- 2.1.1.1. Secondary Instrument
- 2.1.1.2. Primary Instrument
- 2.1.2. Research Approaches
- 2.1.2.1. Bottom-up Approach
- 2.1.2.2. Top-down Approach
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.1.5. Vendor Inclusion Criteria
- 2.1.1. Research Instruments
- 2.2. Forecasting Methodology
- 2.2.1. Methodology for Market Estimation & Forecasting
- 2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Data Feed
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.1.1. Growing prevalence of fungal infection due to climate
- 4.3.1.2. High awareness levels pertaining to myriad fungal infections
- 4.3.1.3. Increased demand for the drugs to combat the related diseases
- 4.3.1.4. Favorable government initiative and corporate funds
- 4.3.2. Restraints
- 4.3.2.1. Continued preference for conventional antifungal drugs
- 4.3.2.2. Growing population with antifungal drug resistance
- 4.3.3. Opportunities
- 4.3.3.1. Increased R&D funding and focus on product innovation
- 4.3.3.2. Patent expiration of branded drugs
- 4.3.4. Challenges
- 4.3.4.1. Potential side effects
- 4.3.4.2. Presence of counterfeit drugs and resistance toward antifungal drugs
5. Global Antifungal Drug Market, by Form
- 5.1. Introduction
- 5.2. Ointments
- 5.3. Powder
- 5.4. Tablets
6. Global Antifungal Drug Market, by Infection Type
- 6.1. Introduction
- 6.2. Superficial Fungal Infection
- 6.3. Systemic Fungal infection
7. Global Antifungal Drug Market, by Therapeutic Indications
- 7.1. Introduction
- 7.2. Aspergillosis
- 7.3. Candidiasis
- 7.4. Dermatophytosis
8. Global Antifungal Drug Market, by Type
- 8.1. Introduction
- 8.2. Allylamines
- 8.2.1. Butenafine
- 8.2.2. Naftifine
- 8.2.3. Terbinafine
- 8.3. Azoles
- 8.3.1. Imidazoles
- 8.3.2. Thiazoles
- 8.3.3. Voricanazole
- 8.4. Echinocandins
- 8.4.1. Anidulafungin
- 8.4.2. Caspofungin
- 8.4.3. Micafungin
- 8.5. Polyenes
- 8.5.1. Amphotericin B
- 8.5.2. Candicidin
- 8.5.3. Hamycin
- 8.5.4. Natamycin
9. Global Antifungal Drug Market, by Geography
- 9.1. Introduction
- 9.2. Americas Antifungal Drug Market
- 9.2.1. Americas Antifungal Drug Market, by Country
- 9.2.1.1. United States
- 9.2.1.2. Brazil
- 9.2.1.3. Canada
- 9.2.1.4. Mexico
- 9.2.1.5. Argentina
- 9.2.2. Americas Antifungal Drug Market, by Form
- 9.2.3. Americas Antifungal Drug Market, by Infection Type
- 9.2.4. Americas Antifungal Drug Market, by Therapeutic Indications
- 9.2.5. Americas Antifungal Drug Market, by Type
- 9.2.1. Americas Antifungal Drug Market, by Country
- 9.3. Europe, Middle East & Africa Antifungal Drug Market
- 9.3.1. Europe, Middle East & Africa Antifungal Drug Market, by Country
- 9.3.1.1. United Kingdom
- 9.3.1.2. Germany
- 9.3.1.3. France
- 9.3.1.4. Saudi Arabia
- 9.3.1.5. United Arab Emirates
- 9.3.1.6. Italy
- 9.3.1.7. Russia
- 9.3.2. Europe, Middle East & Africa Antifungal Drug Market, by Form
- 9.3.3. Europe, Middle East & Africa Antifungal Drug Market, by Infection Type
- 9.3.4. Europe, Middle East & Africa Antifungal Drug Market, by Therapeutic Indications
- 9.3.5. Europe, Middle East & Africa Antifungal Drug Market, by Type
- 9.3.1. Europe, Middle East & Africa Antifungal Drug Market, by Country
- 9.4. Asia-Pacific Antifungal Drug Market
- 9.4.1. Asia-Pacific Antifungal Drug Market, by Country
- 9.4.1.1. China
- 9.4.1.2. Japan
- 9.4.1.3. India
- 9.4.1.4. Australia
- 9.4.2. Asia-Pacific Antifungal Drug Market, by Form
- 9.4.3. Asia-Pacific Antifungal Drug Market, by Infection Type
- 9.4.4. Asia-Pacific Antifungal Drug Market, by Therapeutic Indications
- 9.4.5. Asia-Pacific Antifungal Drug Market, by Type
- 9.4.1. Asia-Pacific Antifungal Drug Market, by Country
10. Competitive Strategic Window
- 10.1. Introduction
- 10.1.1. Leverage Zone
- 10.1.2. Vantage Zone
- 10.1.3. Speculative Zone
- 10.1.4. Bottleneck Zone
11. Competitive News Feed Analysis
12. Company Usability Profiles
- 12.1. Abbott Laboratories
- 12.2. Astellas Pharma Inc.
- 12.3. Bayer HealthCare Pharmaceuticals LLC
- 12.4. Enzon Pharmaceuticals, Inc.
- 12.5. Gilead Sciences, Inc.
- 12.6. GlaxoSmithKline plc
- 12.7. Kramer Laboratories, Inc.
- 12.8. Merck Group
- 12.9. Novartis AG
- 12.10. Pfizer, Inc.
- 12.11. SCYNEXIS, Inc.
- 12.12. Sanofi-Aventis SA
- 12.13. Sigma-Aldrich, Inc.
13. Appendix
- 13.1. Top Reports
- 13.2. Author Details
LIST OF TABLES (33 TABLES)
TABLE 1. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 2. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 6. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 7. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 8. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 10. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 13. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 19. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 20. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 21. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 22. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 23. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 29. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 30. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 31. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 32. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 33. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
LIST OF FIGURES (33 TABLES)
FIGURE 1. GLOBAL ANTIFUNGAL DRUG MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL ANTIFUNGAL DRUG MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL ANTIFUNGAL DRUG MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL ANTIFUNGAL DRUG MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL ANTIFUNGAL DRUG MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. ANTIFUNGAL DRUG MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
FIGURE 12. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2017 VS 2024 (USD BILLION)
FIGURE 13. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 14. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2017 VS 2024 (USD BILLION)
FIGURE 17. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 19. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2017 VS 2024 (USD BILLION)
FIGURE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 21. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 22. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 23. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2017 VS 2024 (USD BILLION)
FIGURE 24. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 25. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 26. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 27. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 28. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 29. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET, BY FORM, 2024
FIGURE 30. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET, BY INFECTION TYPE, 2024
FIGURE 31. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET, BY THERAPEUTIC INDICATIONS, 2024
FIGURE 32. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET, BY TYPE, 2024
FIGURE 33. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET, BY GEOGRAPHY, 2024
- 4.3.1. Drivers
Summary:
Get latest Market Research Reports on Antifungal Drug . Industry analysis & Market Report on Antifungal Drug is a syndicated market report, published as Global Antifungal Drug Market - Premium Insight, Industry Trends, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update). It is complete Research Study and Industry Analysis of Antifungal Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
